Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children.

Barrett JS, Hirankarn S, Holford N, Hammer GB, Drover DR, Cohane CA, Anderson B, Dombrowski E, Reece T, Zajicek A, Schulman SR.

Front Pharmacol. 2015 Jul 28;6:151. doi: 10.3389/fphar.2015.00151. eCollection 2015.

2.

Evaluation of sodium nitroprusside for controlled hypotension in children during surgery.

Drover DR, Hammer GB, Barrett JS, Cohane CA, Reece T, Zajicek A, Schulman SR.

Front Pharmacol. 2015 Jul 6;6:136. doi: 10.3389/fphar.2015.00136. eCollection 2015.

3.

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.

Ng CM, Dombrowsky E, Lin H, Erlich ME, Moody DE, Barrett JS, Kraft WK.

Pharmacotherapy. 2015 Jul;35(7):670-80. doi: 10.1002/phar.1610. Epub 2015 Jul 14.

PMID:
26172282
4.

Breath hydrogen response after lactulose does not predict symptom response to a probiotic fermented milk product in irritable bowel syndrome.

Yao CK, Barrett JS, Philpott H, Chung AR, van Langenberg D, Garg M, Gibson PR.

J Gastroenterol Hepatol. 2015 Jun 11. doi: 10.1111/jgh.13015. [Epub ahead of print]

PMID:
26095068
5.

Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.

van Rongen A, Vaughns JD, Moorthy G, Barrett JS, Knibbe CA, van den Anker JN.

Br J Clin Pharmacol. 2015 Jun 4. doi: 10.1111/bcp.12693. [Epub ahead of print]

PMID:
26044579
6.

Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.

Harskamp-van Ginkel MW, Hill KD, Becker K, Testoni D, Cohen-Wolkowiez M, Gonzalez D, Barrett JS, Benjamin DK Jr, Siegel DA, Banks P, Watt KM; Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee.

JAMA Pediatr. 2015 Jul 1;169(7):678-85. doi: 10.1001/jamapediatrics.2015.132.

PMID:
25961828
7.

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.

Tebas P, Spitsin S, Barrett JS, Tuluc F, Elci O, Korelitz JJ, Wagner W, Winters A, Kim D, Catalano R, Evans DL, Douglas SD.

AIDS. 2015 May 15;29(8):931-9. doi: 10.1097/QAD.0000000000000638.

8.

Challenges and considerations for development of therapeutic proteins in pediatric patients.

Zhang Y, Wei X, Bajaj G, Barrett JS, Meibohm B, Joshi A, Gupta M.

J Clin Pharmacol. 2015 Mar;55 Suppl 3:S103-15. doi: 10.1002/jcph.382.

PMID:
25707958
9.

Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.

Mascarenhas MR, Mondick J, Barrett JS, Wilson M, Stallings VA, Schall JI.

J Clin Pharmacol. 2015 Aug;55(8):854-65. doi: 10.1002/jcph.484. Epub 2015 Mar 23.

PMID:
25689042
10.

Adjuvant therapies for HIV-associated neurocognitive disorders.

McGuire JL, Barrett JS, Vezina HE, Spitsin S, Douglas SD.

Ann Clin Transl Neurol. 2014 Nov;1(11):938-52. doi: 10.1002/acn3.131. Epub 2014 Oct 23. Review.

11.

Novel method to predict body weight in children based on age and morphological facial features.

Huang Z, Barrett JS, Barrett K, Barrett R, Ng CM.

J Clin Pharmacol. 2015 Apr;55(4):447-51. doi: 10.1002/jcph.422. Epub 2015 Jan 6.

PMID:
25370186
12.

Predictors of arterial blood pressure control during deliberate hypotension with sodium nitroprusside in children.

Spielberg DR, Barrett JS, Hammer GB, Drover DR, Reece T, Cohane CA, Schulman SR.

Anesth Analg. 2014 Oct;119(4):867-74. doi: 10.1213/ANE.0000000000000376.

PMID:
25099924
13.

Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant.

Barrett JS, Bajaj G, McGuire J, Wu D, Spitsin S, Moorthy G, Zhao X, Tebas P, Evans DL, Douglas SD.

Curr HIV Res. 2014;12(2):121-31.

PMID:
24862330
14.

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.

Tuck CJ, Muir JG, Barrett JS, Gibson PR.

Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):819-34. doi: 10.1586/17474124.2014.917956. Epub 2014 May 15. Review.

PMID:
24830318
15.

Measurement of the survival probabilities for hot fusion reactions.

Yanez R, Loveland W, Yao L, Barrett JS, Zhu S, Back BB, Khoo TL, Alcorta M, Albers M.

Phys Rev Lett. 2014 Apr 18;112(15):152702. Epub 2014 Apr 17.

PMID:
24785034
16.

ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis.

Zuo XC, Zhang WL, Yuan H, Barrett JS, Hua Y, Huang ZJ, Zhou HH, Pei Q, Guo CX, Wang JL, Yang GP.

Drug Metab Pharmacokinet. 2014;29(4):305-11. Epub 2014 Feb 11.

17.

The grand challenges in obstetric and pediatric pharmacology.

Zajicek A, Barrett JS.

Front Pharmacol. 2013 Dec 30;4:170. doi: 10.3389/fphar.2013.00170. eCollection 2013. No abstract available.

18.

Response to Comment on low FODMAP diet.

Barrett JS, Gibson P.

Nutr Clin Pract. 2013 Dec;28(6):775-6. doi: 10.1177/0884533613503555. No abstract available.

PMID:
24264391
19.

Paediatric models in motion: requirements for model-based decision support at the bedside.

Barrett JS.

Br J Clin Pharmacol. 2015 Jan;79(1):85-96. doi: 10.1111/bcp.12287.

PMID:
24251868
20.

Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.

McCune JS, Bemer MJ, Barrett JS, Scott Baker K, Gamis AS, Holford NH.

Clin Cancer Res. 2014 Feb 1;20(3):754-63. doi: 10.1158/1078-0432.CCR-13-1960. Epub 2013 Nov 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk